Clinical Network Systems Biology: Traversing the Cancer Multiverse

Area of Science:

• Oncology
• Systems Biology
• Precision Medicine

Background:

• High-throughput omics data reveals cancer's complexity beyond genomics, including microenvironments and cell types.
• Cancer systems biology is crucial for understanding tumor initiation, progression, and drug resistance.
• Advancements in targeted therapies and immunotherapies have revolutionized cancer treatment.

Purpose of the Study:

• To highlight the importance of a systems approach in cancer biology.
• To propose improvements in high-throughput clinical trial models for personalized medicine.
• To accelerate drug development and testing for individual cancer patients.

Main Methods:

• Utilizing multifaceted high-throughput omics data.
• Integrating clinical medicine with basic sciences.
• Developing machine learning models for high-throughput clinical trials.

Main Results:

• Identification of key components in tumor initiation, progression, and drug resistance.
• Revolutionized development and approval of cancer therapeutics (e.g., tyrosine kinase inhibitors, immunotherapy).
• Enabled a 'Team Medicine' approach within cancer systems biology.

Conclusions:

• A systems biology framework is instrumental for advancing personalized cancer medicine.
• High-throughput clinical trial models with machine learning can optimize therapy assignment.
• Integrating systems biology into clinical networks can overcome drug development and testing limitations.